Patient reported outcomes in patients with head and neck cancer treated with concurrent chemoradiation with weekly versus bolus cisplatin-Reference-Cited by-同舟云学术

Patient reported outcomes in patients with head and neck cancer treated with concurrent chemoradiation with weekly versus bolus cisplatin

Published:2020-08-19 Issue:12 Volume:42 Page:3670-3677
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Arbab Mona¹²,Chen Yu‐Hui³,Criscitiello Shana³,Glass Jason⁴,Fugazzotto Jo Ann⁴,Killoran Joseph H.¹,Hanna Glenn³,Lorch Jochen³,Haddad Robert I.³,Margalit Danielle N.³^ORCID,Tishler Roy B.³^ORCID,Schoenfeld Jonathan D.³^ORCID

Affiliation:

1. Brigham and Women's Hospital Boston Massachusetts USA

2. Department of Radiation Oncology Indiana University Indianapolis Indiana USA

3. Brigham and Women's Hospital/Dana‐Farber Cancer Institute Boston Massachusetts USA

4. Dana‐Farber Cancer Institute Boston Massachusetts USA

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.26432

Reference19 articles.

1. Quality of Life in Head and Neck Cancer: Where We Are, and Where We Are Going

2. Quality of Life Among Long-Term Survivors of Head and Neck Cancer Treated by Intensity-Modulated Radiotherapy

3. Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy

4. Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

5. Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers;Head & Neck;2022-03-31

2. Patient-Reported Outcomes and Its Application in Cancer;Advances in Clinical Medicine;2022

3. Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients;Radiation Oncology;2021-12